Drug Trial Radar · NCT07222800
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Last checked: Nov 20, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
800
Planned (sponsor's estimate)
Start
Dec 11, 2025
Primary completion
Feb 23, 2030
Study completion Aug 17, 2031
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Oct 30, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to learn more about a new medicine called PF-08634404, and how well it works in people with cancer of the colon or rectum (CRC)). The goal is to understand if the new study medicine, combined with chemotherapy that is approved for colorectal cancer, can help people whose cancer has spread or returned after treatments taken before. To join the study, participants must meet the following conditions: * Be 18 years or older. * Have colorectal cancer that has spread to other parts of your body. * Be in good enough health to receive study treatment. * Should not be pregnant before starting treatment. Participants will be randomized (like flipping a coin) to one of 2 different treatment arms. The first arm (Arm A) will include the new medicine PF-08634404 in combination with chemotherapy that is approved for colorectal cancer, and the second arm (Arm B) will include an approved medicine for colorectal cancer, called Bevacizumab, in combination with chemotherapy that is approved for this type of cancer. Participants and their doctors will not know which arm they are being assigned to. Participants will receive all the study medications through intravenous (IV) infusions, which means the medicine is given directly into a vein. The treatment will be given in cycles, and participants may continue receiving it if it is helping and they are not experiencing serious side effects. The medicine will be given at a clinical site, where trained medical staff will check participants during and after each treatment. * The study is expected to last approximately 33 months for each participant. * Participants will have regular visits to the study site for treatment, health checks, and tests. * After stopping treatment, participants will return for a final visit about 30 to37 days later to check their health and review any side effects. * Follow-up will continue every 12 weeks by phone or in person or by reviewing health records to check on health status and any new treatments.
Conditions
- Intestinal Neoplasms
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Neoplasms by Site
- Digestive System Diseases
- Gastrointestinal Diseases
- Colonic Diseases
- Intestinal Diseases
- Rectal Diseases
- Colorectal Neoplasms
Interventions
PF-08634404Drug
Solution for infusion
BevacizumabBiological
Injection for intravenous use
ChemotherapyDrug
Injection for intravenous use
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors 1.1 (RECIST 1.1) by Blinded Independent Central Review (BICR)Time frame: Approximately 4 years
- Overall survival (OS)Time frame: Approximately 4 years
Locations
372 sites in 17 countries. Site status is shown where the registry gives one.
Ironwood Cancer & Research Centers
Chandler, Arizona · Recruiting
Banner Gateway Medical Center
Gilbert, Arizona · Not yet recruiting
Banner MD Anderson Cancer Center
Gilbert, Arizona · Not yet recruiting
Ironwood Cancer & Research Centers
Gilbert, Arizona · Recruiting
Ironwood Cancer & Research Centers
Glendale, Arizona · Recruiting
Ironwood Cancer & Research Centers
Goodyear, Arizona · Recruiting
Ironwood Cancer & Research Centers
Mesa, Arizona · Recruiting
Ironwood Cancer & Research Centers
Mesa, Arizona · Recruiting
Banner MD Anderson Cancer Center at Banner University Medical Center- Phoenix
Phoenix, Arizona · Not yet recruiting
Banner MD Anderson Cancer Center
Phoenix, Arizona · Not yet recruiting
Banner University Medical Center Phoenix
Phoenix, Arizona · Not yet recruiting
Ironwood Cancer & Research Centers
Phoenix, Arizona · Recruiting
Mayo Clinic Building- Phoenix
Phoenix, Arizona · Recruiting
Mayo Clinic Hospital
Phoenix, Arizona · Recruiting
Mayo Clinic
Scottsdale, Arizona · Recruiting
Ironwood Cancer & Research Centers
Scottsdale, Arizona · Recruiting
Banner Boswell Medical Center
Sun City, Arizona · Not yet recruiting
Banner MD Anderson Cancer Center
Sun City, Arizona · Not yet recruiting
BMDACC Boswell
Sun City, Arizona · Not yet recruiting
Highlands Oncology Group
Fayetteville, Arkansas · Recruiting
Highlands Oncology Group
Rogers, Arkansas · Recruiting
Highlands Oncology Group
Springdale, Arkansas · Recruiting
UCSF at Berkeley Outpatient Center
Berkeley, California · Recruiting
Alta Bates Summit Medical Center-Herrick Campus Comprehensive Cancer Center
Berkeley, California · Recruiting
UCSD Medical Center - Encinitas
Encinitas, California · Recruiting
Palo Alto Medical Foundation - Fremont Center
Fremont, California · Recruiting
UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion)
La Jolla, California · Recruiting
UC San Diego Moores Cancer Center
La Jolla, California · Recruiting
UCSD Koman Family Outpatient Pavilion
La Jolla, California · Recruiting
Palo Alto Medical Foundation - Palo Alto Center
Palo Alto, California · Recruiting
Roseville Medical Plaza Care Center
Roseville, California · Recruiting
Sutter Medical Center, Sacramento Infusion Center at Roseville
Roseville, California · Recruiting
University of California, Davis Comprehensive Cancer Center
Sacramento, California · Recruiting
University of California, Davis Medical Center
Sacramento, California · Recruiting
UC San Diego McGrath Outpatient Pavilion - Hillcrest
San Diego, California · Recruiting
UC San Diego Medical Center - Hillcrest
San Diego, California · Recruiting
UC San Diego Medical Center - Rancho Bernardo
San Diego, California · Recruiting
UCSF at China Basin
San Francisco, California · Recruiting
UCSF at Mount Zion
San Francisco, California · Recruiting
UCSF at Parnassus
San Francisco, California · Recruiting
Showing 40 of 372 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.